162 related articles for article (PubMed ID: 7477118)
41. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
[TBL] [Abstract][Full Text] [Related]
42. Multiple drug resistance in osteosarcoma.
Rosier RN; Teot LA; Hicks DG; Schwartz C; O'Keefe RJ; Puzas JE
Iowa Orthop J; 1995; 15():66-73. PubMed ID: 7634047
[No Abstract] [Full Text] [Related]
43. [P-glycoprotein expression in osteosarcoma].
Pösl M; Grahl K; Amling M; Werner M; Ritzel H; Stenzel I; Hentz M; Winkler K; Delling G
Pathologe; 1996 Jan; 17(1):50-5. PubMed ID: 8685096
[TBL] [Abstract][Full Text] [Related]
44. [Relationship between the expression of insulin-like growth factor I receptors and apoptosis after preliminary chemotherapy, in child and adolescent osteosarcoma].
Rytwiński K; Wnuk A; Woźniak W; Rychłowska M
Med Wieku Rozwoj; 2004; 8(2 Pt 1):267-73. PubMed ID: 15738602
[TBL] [Abstract][Full Text] [Related]
45. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.
Imbriaco M; Yeh SD; Yeung H; Zhang JJ; Healey JH; Meyers P; Huvos AG; Larson SM
Cancer; 1997 Oct; 80(8):1507-12. PubMed ID: 9338476
[TBL] [Abstract][Full Text] [Related]
46. P-glycoprotein and multidrug resistance.
Mesa-Tejada R
N Engl J Med; 1996 May; 334(20):1335-6; author reply 1336-7. PubMed ID: 8609959
[No Abstract] [Full Text] [Related]
47. [Analysis of DNA histograms and histopathologic assessment of necrosis after preoperative chemotherapy of osteosarcoma in children and youth].
Rytwiński K; Wnuk A; Klepacka T; Bilska K
Med Wieku Rozwoj; 2000; 4(2 Suppl 2):36-43. PubMed ID: 11178327
[TBL] [Abstract][Full Text] [Related]
48. P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy.
Chan HS; Grogan TM; Haddad G; DeBoer G; Ling V
J Natl Cancer Inst; 1997 Nov; 89(22):1706-15. PubMed ID: 9390540
[TBL] [Abstract][Full Text] [Related]
49. Tumor necrosis and prognosis in osteosarcoma.
Willén H
Acta Orthop Scand Suppl; 1997 Feb; 273():126-9. PubMed ID: 9057602
[No Abstract] [Full Text] [Related]
50. Clinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma.
Kumta SM; Zhu QS; Lee KM; Griffith J; Chow LT; Leung PC
Int Orthop; 2001; 25(5):279-82. PubMed ID: 11794258
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of bax, cytochrome C, and caspase-8 protein expression in primary osteosarcoma.
Kaseta MK; Gomatos IP; Khaldi L; Tzagarakis GP; Alevizos L; Themistocleous GS; Leandros E; Soucacos PN
Hybridoma (Larchmt); 2007 Dec; 26(6):355-62. PubMed ID: 18158779
[TBL] [Abstract][Full Text] [Related]
52. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.
Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K
Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343
[TBL] [Abstract][Full Text] [Related]
53. P-glycoprotein and multidrug resistance.
Johnston JM
N Engl J Med; 1996 May; 334(20):1336; author reply 1336-7. PubMed ID: 8609961
[No Abstract] [Full Text] [Related]
54. Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas.
Kusuzaki K; Hirata M; Takeshita H; Murata H; Hashiguchi S; Ashihara T; Hirasawa Y
Cancer Lett; 1999 Apr; 138(1-2):203-8. PubMed ID: 10378794
[TBL] [Abstract][Full Text] [Related]
55. Spontaneous necrosis in osteosarcomas.
von Hochstetter AR
Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):5-8. PubMed ID: 2113741
[TBL] [Abstract][Full Text] [Related]
56. Osteosarcoma with cytokeratin expression: a clinicopathological study of six cases with an emphasis on differential diagnosis from metastatic cancer.
Okada K; Hasegawa T; Yokoyama R; Beppu Y; Itoi E
J Clin Pathol; 2003 Oct; 56(10):742-6. PubMed ID: 14514776
[TBL] [Abstract][Full Text] [Related]
57. P-glycoprotein and multidrug resistance.
Duensing S; Ganser A; Atzpodien J
N Engl J Med; 1996 May; 334(20):1336; author reply 1336-7. PubMed ID: 8609960
[No Abstract] [Full Text] [Related]
58. Prognostic significance of spontaneous tumour necrosis in osteosarcoma.
Björnsson J; Inwards CY; Wold LE; Sim FH; Taylor WF
Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):195-9. PubMed ID: 8236813
[TBL] [Abstract][Full Text] [Related]
59. Morphological changes in osteosarcoma after chemotherapy--COSS 80.
Delling G; Krumme H; Salzer-Kuntschik M
J Cancer Res Clin Oncol; 1983; 106 Suppl():32-7. PubMed ID: 6577012
[TBL] [Abstract][Full Text] [Related]
60. Current status of DNA cytometry in osteosarcoma.
Bauer HC
Cancer Treat Res; 1993; 62():151-61. PubMed ID: 8096728
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
